Here is the critical difference between insulin and semaglutide
Int J Pharm 436:840850 Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, Ito Y, Kamon J, Tsuchida A, Kumagai K, Kozono H, Hada Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Awazawa M, Takamoto I, Froguel P, Hara K, Tobe K, Nagai R, Ueki K, Kadowaki T (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
When it comes to Ozempic, though, its best for patients to stick to their respective countries
If thats true, weight loss is not the whole story but weight loss is likely an important contributor because excess adiposity promotes chronic inflammation, hormonal dysregulation, insulin resistance, and other processes linked to cancer development